To include your compound in the COVID-19 Resource Center, submit it here.

NICE recommends MabThera for NHL

The U.K.'s NICE issued a final appraisal determination (FAD)

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE